haemophilia: latest news - GoINPHARMA
Monday, 25 March 2019 - 9:02


Biomarin announces new investments in Ireland

US-based biotech company Biomarin keeps investing in Ireland and expects to complete three new laboratories in Cork before Q3 2018 and to hire 50 new employees in the Cork site, which already has a workforce of 365. Biomarin reached record…

Sanofi Genzyme-Alnylam agreement for hemophilia treatment now broadened

Alnylam Pharmaceuticals today announced that, pursuant to the companies’ global alliance signed in January 2014, Sanofi Genzyme elected to co-develop and co-commercialize fitusiran, an investigational product for the treatment of hemophilia and RBD (rare bleeding disorders), in the United States,…